Atıf Formatları
Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

L. Filik Et Al. , "Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen," TRANSPLANTATION PROCEEDINGS , vol.38, no.2, pp.496-498, 2006

Filik, L. Et Al. 2006. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen. TRANSPLANTATION PROCEEDINGS , vol.38, no.2 , 496-498.

Filik, L., Karakayali, H., Moray, G., Dalgic, A., Emiroglu, R., Ozdemir, N., ... Colak, T.(2006). Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen. TRANSPLANTATION PROCEEDINGS , vol.38, no.2, 496-498.

Filik, L Et Al. "Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen," TRANSPLANTATION PROCEEDINGS , vol.38, no.2, 496-498, 2006

Filik, L Et Al. "Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen." TRANSPLANTATION PROCEEDINGS , vol.38, no.2, pp.496-498, 2006

Filik, L. Et Al. (2006) . "Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen." TRANSPLANTATION PROCEEDINGS , vol.38, no.2, pp.496-498.

@article{article, author={L Filik Et Al. }, title={Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen}, journal={TRANSPLANTATION PROCEEDINGS}, year=2006, pages={496-498} }